Hansa Biopharma AB (publ) (LON: 0RC7)
London
· Delayed Price · Currency is GBP · Price in SEK 84.70
-19.80 (-18.94%)
Jul 22, 2022, 8:39 AM BST
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 158.75 million as of January 23, 2025. Its market cap has increased by 56.38% in one year.
Market Cap
158.75M
Enterprise Value
188.65M
Revenue
13.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
84.70
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 2.62M to 158.75M, an increase of 5,964.11%. That is a compound annual growth rate of 27.75%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.80B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 2.00B |
| Oxford Nanopore Technologies | 1.37B |